Background -Sudden cardiac death (SCD) is a major cause of mortality in adults with
Introduction
Sudden cardiac death (SCD) accounts for 15% of total mortality and 5.6% of annual mortality in the Unites States and the vast majority is due to fatal arrhythmia. Similar event rates have also been reported in Europe. Approximately 70% of SCD cases are attributable to coronary heart disease and 10% to acquired or hereditary cardiac diseases. [1] [2] [3] In patients with ischemic and nonischemic cardiomyopathy (CMP) left ventricular ejection fraction 35% is the most important predictor of SCD and implantable cardioverter defibrillator (ICD) therapy has been proven to be effective in primary and secondary prevention of SCD in these patients. 4, 5 Similarly, in adults with congenital heart disease (CHD), SCD is a prominent cause of death (19%-26%) 6, 7 . During the past few decades life expectancy has remarkably improved in CHD due to better surgical and interventional techniques. 8, 9 The annual incidence of SCD in the entire CHD population is relatively low (0.09% per year) but much higher than in age-matched controls. When applied to the adults with CHD in USA and Canada, approximately 765 and 90 SCD events will occur annually, respectively. 10, 11 Additionally, as the majority of infants born with CHD will now survive into adulthood the prevalence of SCD will steadily increase. Adults with repaired tetralogy of Fallot (TOF) and or Mustard or Senning repair for complete transposition of great arteries (TGA) have been studied previously and several potential risk factors for SCD have been identified. [12] [13] [14] [15] Unfortunately, the predictive value of these risk factors is relatively low and it is uncertain whether these proposed risk factors are relevant to other forms of CHD. Moreover, as the CHD population is growing and ageing, the risk profile for SCD might have changed.
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Methods

Study Design and Population
This was an international retrospective case-controlled study of adults (age 18 years) with CHD and proven or presumed arrhythmic death. Cases were defined as adult CHD patients with SCD and controls were alive adult CHD patients without SCD. Patients with moderate or severe heart failure were not excluded. Those patients with non-arrhythmic causes of sudden death were excluded. For each SCD case two control patients who were alive were matched to 1) age (plus or minus 5 years of corresponding SCD case), 2) gender, 3) diagnosis 4) type of surgical intervention (e.g prior shunt, palliative or corrective surgery, valve replacements etc) 5) date of surgical repair (within five years of corresponding SCD case) and 6) center (when available).
Cases and controls were recruited from the Concor database, the Toronto Congenital Cardiac arrhythmic death by default (abrupt loss of consciousness and disappearance of pulse but no further data).
17
Data collection
Information about circumstances of SCD, location, cardiopulmonary resuscitation (CPR), or autopsy was collected from general practitioners, relatives, hospitals involved in follow up and ambulance care in region. Based on this information, the actual or probable cause of SCD was determined. Medical records were reviewed and most recent data before the event were obtained and compared with controls at the same time frame. The median time between last outpatient or clinical visit and death was 4 months for the SCD cases (25 th percentile 1 month, 75 th percentile 9 months) and the median time since last outpatient or clinical visit was 2 months for the controls (25 th percentile was 0 months and 75 th percentile 12 months). The complexity of the congenital defect was classified as mild, moderate and complex. 18 Eisenmenger syndrome was defined as the presence of systemic pulmonary arterial pressures or high pulmonary vascular resistance with reversed or bidirectional shunts or in single ventricle through a large defect between the systemic and pulmonary circulation at ventricular, atrial or aorto-pulmonary levels. 19 All patients were considered to have contraindications for cardiac surgery because of high pulmonary vascular resistance. Patients with progressive or severe pulmonary hypertension after surgical repair of defects were not considered as Eisenmenger syndrome.
Arrhythmias were classified according to the ACC/AHA/ESC guidelines. 20 Arrhythmic symptoms included palpitations or (pre)syncope. Rhythm (spontaneous or paced), RR interval, determined. Medical records were reviewed and most recent data before the even en nt we w w re re re o o obt bt btai ai aine n d
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Characteristics of Sudden Cardiac Deaths Versus Controls
Overall, 1189 of 25790 adults (5%) died of whom 213 died suddenly (19%). The he e c cau au a se se ses s s of of of udden death were proven or presumed arrhythmia in 171 (80%), aortic dissection or aneurysm u upt pt tur ur ure e e in in in 1 1 19 9 9 (9 ( %) %) %), , cerebrovascular accident in 8 8 8 ( ( (4 4 4%), pulmonary ry y emb mb mbol ol o ism/hemorrhage in 8
The underlying cardiac lesions were mild, moderate and severe CHD in 12%, 33% and 55% of the SCDs, respectively. The more specific underlying cardiac defects of the 171 SCDs are shown in Figure 1 . Characteristics of SCD cases versus controls are summarized in Table 1 . For 165
SCDs, 310 suitable control patients were identified. For 20 SCDs we were able to find only one control patient and for six SCDs none. These 6 SCDs were excluded from further analyses.
SCDs were more often in a worse functional class (24% vs 5%, P<0.005) than controls and subsequently more likely to be using heart failure drugs (42% vs 14%, P<0.001). Both SVTs (40% vs 25%, P=0.001) and nonsustained VT (NSVT, 15% versus 9%, P=0.032) occurred more frequently in SCDs compared to controls and anti-arrhythmic medication was also used more frequently (24% vs 12%, P=0.001). Amiodarone was the most frequently prescribed drug for SCDs (65%), followed by sotalol (20%). In contrast, controls used sotalol (46%) more frequently than amiodarone (38%). Table 2 shows the clinical parameters of the SCDs and controls.
Clinical Parameters Associated with Sudden Arrhythmic Death
Univariate and multivariate analysis are summarized in Table 3 . Clinical parameters associated with SCD in multivariate analysis were documented SVTs (OR 3.5, 95% CI 1.5-7.9, P=0.004), QRS duration (OR 1.34, (per 10 ms increase) 95% CI 1.10-1.34, P=0.008), QT dispersion (OR Neither heart failure symptoms or worse NHYA functional class, nor documented ventricular arrhythmias and anti-arrhythmic medication altered the risk of SCD. Cardiac surgery and subsequently ventriculotomy with myocardial scar was not found as a specific risk factor for SCD as this was a matching criteria for controls.
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Clinical Parameters Associated with Sudden Arrhythmic Death Among Various
Congenital Heart Disease Conditions
Overall, 33 SCD cases (58% male) had Eisenmenger syndrome. Eisenmenger syndrome resulted predominantly from septal defects (58%) and univentricular heart physiology (27%).
The underlying cardiac defects were complete transposition of the great arteries (TGA) in 18
SCDs (70% male) and congenitally corrected-TGA (cc-TGA) in 12 patients. Fifteen of the 18 complete TGA patients (83%) were treated with Mustard or Senning repair, two with an arterial switch procedure (11%) and one with a Rastelli procedure (1%). Seven of the 18 complete TGA patients (39%) also had repaired VSD. Nine of the 12 cc-TGA patients (75%) had associated cardiac defects (7 VSD and pulmonary stenosis and 2 Ebstein-like malformation of tricuspid valve). Of these, six patients were treated with VSD closure and five also with a left ventricular to pulmonary artery conduit. After surgical repair 27 of the 30 SCDs with complete TGA or cc-TGA had (90%) had a systemic right ventricle.
Overall, 26 patients with SCD (69% male) had surgically repaired TOF of whom 12 has had a previous palliative shunt (46%). Surgical repair took place at mean age of 12±14 y and pulmonary valve replacement with a homograft was performed in 31% of the patients during valve stenosis (AS, n=9, mean age 33±8 y), isolated bicuspid aortic valve (BAV, n=5, mean age 46±23 y) and coarctation of the aorta (CoA, n=7, mean age 35±18 y). All CoA were complex;
five had BAV and two VSD. Overall, 18 of 21 patients had undergone surgery for severe AS.
The incidence of moderate to severe AS was similar for SCDs and controls. In this subgroup no clinical variables associated with SCD were found.
Nineteen SCDs (11%) had septal defects including atrial septal defect (ASD, n=8), ventricular septal defect (VSD, n=9) and atrioventricular septal defect (AVSD, n=2). Thirteen patients had surgical closure and four patients percutaneous closure of the defect. Only two patients (1 ASD, 1 VSD) were untreated as their shunt was not hemodynamically relevant.
Patients with ASD were older (mean age 60±21 y) than patients with a VSD or AVSD (mean age 29±8 y) and two of them had documented coronary artery disease. Postoperative atrio-ventricular block was present in three SCD cases and was not associated with SCD. Moderately to severely impaired SVF and PVF was present in 18% and 1% of SCDs and controls, respectively.
Overall, 25 SCD cases had a cyanotic cardiac condition without Eisenmenger physiology of which seven were palliated with a Fontan procedure (4%, 86% male). There was no significant difference in baseline characteristics, and clinical parameters between SCDs and controls with a Fontan procedure. Of the remaining 18 cyanotic SCDs (11%, 61% female) seven were palliated with an aortapulmonary shunt and three with a bidirectional cavopulmonary anastomosis.
Discussion
To the best of our knowledge this is the largest international study investigating the 
Ventricular Dysfunction
The relationship between left ventricular systolic dysfunction and death due to heart failure and ventricular arrhythmias in patients with ischemic heart disease is well established. 22, 23 This study shows that systemic ventricular dysfunction is associated with SCD in a general CHD population, particularly in adults with (cc) TGA, cyanotic patients with or without Eisenmenger physiology and surgically repaired TOF patients. Published results of the predictive value of systemic ventricular dysfunction in repaired TGA are conflicting. 24, 25 In the present study impaired systolic function of the systemic and subpulmonic ventricle were associated with SCD in Eisenmenger syndrome patients and surgically repaired TOF patients. In one of the largest cohorts of Eisenmenger syndrome (n=171) impaired ventricular function, neither systemic nor subpulmonic, was predictive of death. In that study 20 patients died of whom 11 suddenly. 26 The association of impaired systolic function of the systemic and subpulmonic ventricle with SCD has been described earlier in TOF patients. 14 Left ventricular dysfunction in TOF may in part be explained by older age at repair with longer periods of volume overload and chronic hypoxemia, right ventricular dysfunction leading to left ventricular dysfunction and regurgitation of the aortic
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In this study none of the SCDs with moderately to severely impaired systemic ventricular function who may have been considered at "high risk" of SCD received an ICD for primary prevention of SCD. This may in part be attributable to the era in which these deaths occurred.
Secondary ICD prophylaxis for SCD via the transvenous route has been available since the mid-90's and the benefit of primary prophylaxis for SCD was appreciated with the publication of 
QRS duration and QT dispersion
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In healthy control subjects, QT dispersion ranges from 10 to 70ms. However, overlap in values between healthy controls and cardiac patients or between patients with and without adverse outcome have been reported. 29 Prognostic information on QT dispersion in CHD is limited. 30 In this study increased QT dispersion was associated with SCD and was above the upper normal limit in 50% of SCD cases. The QT dispersion was within the normal range in the majority of controls (84%).
Documented arrhythmias
In the present study atrial flutter or fibrillation was associated with SCD, especially in TGA and TOF. This association has been described earlier in patients with TGA but not in TOF. 13 Further studies are needed to clarify whether atrial tachyarrhythmias are a surrogate marker for SCD or a consequence of ventricular dysfunction. Documented NSVT's were uncommon in SCD cases (18%) and not associated with SCD. Anti-arrhythmic drugs were used more often by the SCDs than controls as arrhythmias were more often present in SCDs. One might speculate that lack of back-up pacing in these patients might have been a contributing factor with bradycardia-induced ventricular arrhythmias leading to SCD.
Sudden Arrhythmic Death in Septal Defects
While repaired septal defects are considered benign and ventricular arrhythmias or SCD have been reported as uncommon 31 , in the present cohort 11% of SCD cases had septal defects (89% were closed). The few untreated septal defects were not hemodynamically relevant. Patients with ASD repair were older and potentially coronary artery disease rather than CHD might have been
Documented arrhythmias
n the present study atrial flutter or fibrillation was associated with SCD, especially in TGA and TO OF F. F. T T Thi hi his s s as a a s soci ci iat at atio ion has been described earlie er r r in in patients with h T T TGA A A b b bu u ut not in TOF. 13 Further t tud d die i s are need ed ded ed e to o cl c c a ar arif if ify y wh wh w et ethe he her r a a atr ri ial t tac ac chya a arr rh hyt t thm hm mia ia as ar are e a a su urr rrog og gat ate e e m ma mark rk ker er e f f for or S S SCD CD CD o o or a co on ns nseq eq eque uenc nc ce e e of of v v ve en ntr tri ic cu ul ular ar d d dys ys y fu fu func nc nct ti tion on n. Do Do Docu cu ume me m n nt nte ed e N NSV SV SVT' T' 's s s w we were re re u un n nco om ommo mo mon n n in in n S S SCD CD D c cas ase es es 18%) and no not t t as as a so so soci ci c at at ated ed e w w wit it th h h SC SC SCD D D. . An An Anti ti i-a -a arr rr rrhy hy hyth th hmi mi mic c c dr dr rug ug ugs s s we we were re re u us s sed ed ed m m mor or ore e e of of fte te ten n n by by by the SCDs 
Study Limitation
This study has limitations inherent to any retrospective study. Data collection was limited to data in medical records. Rhythm documentation at the time of event or autopsy reports was not available for all SCDs and thus it is not possible to ascertain that their death were solely arrhythmic in nature. On the other hand, the actual incidence of SCD might have been underestimated because of the strict definitions applied in this study. Data on syncope lacked in majority of the SCD cases and could therefore not be used for risk stratification. Patients were retrieved from 3 databases with different inclusion periods which precluded determination of the annual incidence rate of SCD in the general CHD population. Moreover, the prognosis of patients and thus the incidence of SCD might have been influenced by changes in treatment recommendations during the study period. Assessment of ventricular function may be challenging in CHD due to abnormal ventricular geometry. Cardiac magnetic resonance imaging (cMRI) is more accurate in measuring EF in some cardiac lesions (e.g. systemic right ventricle).
Unfortunately in this study quantification of ventricular EF by cardiac MRI was frequently lacking, in which case qualitative data were used. Furthermore, a cut-off value for pulmonary arterial blood pressure to define Eisenmenger syndrome was not used in this study. The number of patients among the various cardiac defects was small and therefore multivariate analyses were not performed for these subgroups. A prospective analysis of the risk factors reported here would principally be preferable but is extremely difficult to achieve due the low incidence of SCD and the heterogeneity within the CHD population.
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Conclusion and clinical implications
We have identified several clinical parameters associated with SCD in adults with a broad spectrum of CHD including systemic right ventricles. These parameters may be helpful for identifying high risk patients and may guide clinicians in their treatment strategy. The identified clinical parameters are similar to the risk factors for SCD in ischemic cardiomyopathy and include documented SVTs, impaired ventricular function, increased QRS duration and prolonged QT dispersion. It is important to be aware that SCD occurs at a relatively young age in CHD. (15) 27 (9) 0.032 Br Br rad ad adya ya yarr rr rrhy hy h th hmi mi m as a 23 (14) 33 33 11 11) ) ) 20 20 20 ( (7) 
